Liver transplantation and hepatocellular carcinoma: is TIPS deleterious? A multicentric retrospective study of the ARCHET research group with propensity score matching
- 13 April 2023
- journal article
- research article
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 408 (1) , 1-9
Abstract
Purpose A transjugular intrahepatic portosystemic shunt (TIPS) before the liver transplantation (LT) has been considered a contraindication in cases of hepatocellular carcinoma (HCC) because of the risk of tumour growth. We aimed to assess the impact of TIPS on incidental HCC and oncological outcomes in transplanted patients with pre-existing HCC. Methods All consecutive transplanted patients for cirrhosis who had a previous TIPS with or without HCC were included. Between 2007 and 2014, 1912 patients were transplanted. We included 122 (6.3%) patients having TIPS before LT. A 1:3 matched cohort of 366 patients (18.9%) having LT without previous TIPS was selected using a propensity score. Incidental HCC rate and risk factor of HCC recurrence were evaluated using multivariate analysis with a competing risk model. Results Before LT, in the TIPS group, 27 (22.1%) had an HCC vs. 81 (22.1%) in the control group (p = 1). The incidental HCC rate was similar: 10.5% (10/95) in the TIPS group vs. 6.3% (18/285) in the control group (p = 0.17). Recurrence occurred in 1/27 (3.7%) patient in the TIPS group and in 7/81 (8.6%) patients in the control group, without significant difference (p = 0.51). After multivariate regression, patient’s gender (p < 0.01) was significantly associated with HCC recurrence while a tumour within Milan criteria (p = 0.01, sHR: 0.17 [0.04; 0.7]) and an incidental HCC (p<0.01) were found to be protector factors against HCC recurrence. Conclusion TIPS did not worsen the prognosis of transplanted patients for HCC. TIPS should no longer be contraindicated for oncological reasons in patients with HCC waiting for an LT.Keywords
This publication has 39 references indexed in Scilit:
- Does the Transjugular Intrahepatic Portosystemic Influence the Outcome of Liver Transplantation?Transplantation Proceedings, 2012
- Early Use of TIPS in Patients with Cirrhosis and Variceal BleedingNew England Journal of Medicine, 2010
- Management of Hepatocellular Carcinoma *Hepatology, 2005
- Influence of TIPS on Development of Hepatocellular Carcinoma in Cirrhosis *Hepatology, 2005
- Patients with cirrhosis and bare‐stent TIPS may have increased risk of hepatocellular carcinoma†Hepatology, 2005
- Liver transplantation and transjugular intrahepatic portosystemic shuntTransplantation Proceedings, 2003
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Role of endogenous nitric oxide in liver-specific functions and survival of cultured rat hepatocytesXenobiotica, 2001
- Endothelial Cells Lining Transjugular Intrahepatic Portasystemic Shunts Originate in Hepatic Sinusoids: Implications for Pseudointimal HyperplasiaHepatology, 1999
- Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with CirrhosisNew England Journal of Medicine, 1996